A wireless shoe insert meant to help people manage diabetic peripheral neuropathy goes on sale Wednesday after some significant design changes from an earlier prototype delayed the release by nearly a year.
Orpyx Medical Technologies, of Calgary, Alberta, is introducing the SurroSense Rx system to U.S. customers only through its website, in men's sizes 5-13 and women's sizes 6-12. Early orders...
A Canadian startup company is developing a wireless shoe insert that will help people with diabetes manage peripheral nerve damage and hopefully prevent amputations that often stem from diabetic foot ulcers.
Orpyx Medical Technologies, based in Calgary, Alberta, will soon be seeking regulatory approval in the U.S. and Canada to sell SurroSense Rx, an insole that that collects data of where...
